Oxandrolone 50 - Livewell Pharmaceuticals

First introduced as Anavar in 1962,Oxandrolone was developed by G.D. Searle & Co. for therapeutic use in treating catabolic illnesses and delayed growth. It was known for strong anabolic properties paired with low androgenic activity. The drug was widely marketed in various countries, including the United States, Brazil, and Australia. Despite its clinical benefits, Searle discontinued production in 1989 due to negative public perception of anabolic steroids. The compound returned to the market in 1995 as Oxandrin,now directed toward rare medical conditions through the FDA orphan drug program.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandrolone 50 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.